Inspire Medical Systems, Inc. EBIT for the Trailing 12 Months (TTM) ending March 31, 2025: USD 72.21 M

Inspire Medical Systems, Inc. EBIT is USD 72.21 M for the Trailing 12 Months (TTM) ending March 31, 2025, a -336.28% change year over year. EBIT means earnings before interest and taxes, it is calculated as operating income plus non-operating income.
  • Inspire Medical Systems, Inc. EBIT for the Trailing 12 Months (TTM) ending March 31, 2024 was USD -30.56 M, a -38.30% change year over year.
  • Inspire Medical Systems, Inc. EBIT for the Trailing 12 Months (TTM) ending March 31, 2023 was USD -49.53 M, a 21.80% change year over year.
  • Inspire Medical Systems, Inc. EBIT for the Trailing 12 Months (TTM) ending March 31, 2022 was USD -40.67 M, a -26.14% change year over year.
  • Inspire Medical Systems, Inc. EBIT for the Trailing 12 Months (TTM) ending March 31, 2021 was USD -55.06 M, a 40.91% change year over year.
Key Data
Date EBIT EBITDA Net Income EPS (Diluted)